Clinical Trial Update: Xingbai Ji Formula Combined with Chemotherapy and Sintilimab in Metastatic Multi-Target Mutation-Negative Non-Small Cell Lung Cancer: a Clinical Trial [NA]

View source ↗

Summary

A clinical trial update describing a study of Xingbai Ji Formula combined with chemotherapy and Sintilimab for metastatic multi-target mutation-negative non-sma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Sintilimab (sintilimab)
• Xingbai Ji Formula

Snippet

Sponsor: Jiangxi Provincial People's Hopital | Conditions: Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer Recurrent | NA | Status: NOT_YET_RECRUITING